Anna McCall, MD
Family Medicine · Bowie, MDNPI 1306092135
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $22,555 of the $24,388 with a category attached, or 92.5%. Takeda Pharmaceuticals U.S.A., Inc. accounts for 86.9% of it on its own, with 19 other manufacturers making up the rest. Reporting peaked in 2020 at $21,180 and has fallen 97.9% since, to $443 in 2025. Among family medicine clinicians in MD with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 102 payments — averaging $239.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Takeda Pharmaceuticals U.S.A., Inc.$21K
- Shire North American Group Inc$1K
- Novo Nordisk$511
- AbbVie$341
- AstraZeneca$218
- Pfizer$157
- plus $589 from 14 others
What the payments were for
- Consulting fees$22,55592%
- Food & beverage$1,8338%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $21,198 |
| Shire North American Group Inc | 2 | $1,375 |
| Novo Nordisk | 19 | $511 |
| AbbVie | 25 | $341 |
| AstraZeneca | 6 | $218 |
| Pfizer | 7 | $157 |
| Lilly USA, LLC | 6 | $102 |
| Xeris Pharmaceuticals, Inc. | 5 | $90 |
| Amgen | 4 | $62 |
| Exact Sciences | 3 | $56 |
| Bayer | 2 | $50 |
| Merck | 2 | $45 |
| Abbott | 2 | $39 |
| Eisai Inc. | 2 | $38 |
| Boehringer Ingelheim | 1 | $23 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $19 |
| E.r. Squibb & Sons, L.L.C. | 1 | $19 |
| Dexcom, Inc. | 1 | $15 |
| Sanofi-aventis U.S. LLC | 1 | $15 |
| Novartis | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$24,388 in reported general payments places this provider in the 95th percentile of 1,193 family medicine providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atorvastatin Calcium | 32 | $236 |
| Rosuvastatin Calcium | 20 | $231 |
| Amlodipine Besylate | 43 | $229 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 16 | $190 |
| Metformin Hcl | 14 | $71 |
| Hydrochlorothiazide | 24 | $31 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Bowie
- Tramaine DavisBowie$43K
- Karen DonaldsonBaltimore$899K
- Louis JacquesBaltimore$522K
- Michael ObiefuneBaltimore$291K
- Thomas LawrenceBerlin$254K
- Casey ScottCambridge$88K
- Daljeet SalujaBaltimore$63K
- Sanjay SaxenaHagerstown$60K
- Cynthia KleppingerSilver Spring$51K
- Alkesh PatelColumbia$42K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.